| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/02/2010 | US20100304415 Chromatography of metal complexes |
| 12/02/2010 | US20100304414 Methods and Devices for Detecting Methicillin Resistant Staphylococcus Aureus |
| 12/02/2010 | US20100304407 Fluorescence Lifetime and Fluorescence Assays |
| 12/02/2010 | US20100304396 Animal health diagnostics |
| 12/02/2010 | US20100304395 Method, Program, and System for Normalizing Gene Expression Amounts |
| 12/02/2010 | US20100304394 Screening methods involving the detection of short-lived proteins |
| 12/02/2010 | US20100304393 Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapy |
| 12/02/2010 | US20100304392 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 12/02/2010 | US20100304391 Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis |
| 12/02/2010 | US20100304390 Methods for detecting gene dysregulations |
| 12/02/2010 | US20100304389 Preparation And Isolation of 5' Capped mRNA |
| 12/02/2010 | US20100304388 Biomarker For Successful Aging Without Cognitive Decline |
| 12/02/2010 | US20100304387 Methods and compositions for signal enhancement using multivalent interactions |
| 12/02/2010 | US20100304386 Enzymes for amplification and copying bisulphite modified nucleic acids |
| 12/02/2010 | US20100304385 Assay |
| 12/02/2010 | US20100304384 Method of identifying compounds that induce or inhibit endoplasmic reticulum stress or oxidative stress |
| 12/02/2010 | US20100304383 Biomarkers for prenatal diagnosis of congenital cytomegalovirus |
| 12/02/2010 | US20100304382 Gene Defects and Mutant ALK Kinase in Human Solid Tumors |
| 12/02/2010 | US20100304381 Fluorescent nucleobase conjugates having anionic linkers |
| 12/02/2010 | US20100304380 Quantitative DNA Methylation Imaging of Cells and Tissues |
| 12/02/2010 | US20100304379 Spores for the stabilization and on-site application of bacterial whole-cell biosensing systems |
| 12/02/2010 | US20100304378 Method for Detecting or Quantifying a Truncating Mutation |
| 12/02/2010 | US20100304377 Method of detecting norovirus rna |
| 12/02/2010 | US20100304376 Epigenetic Silencing of Cyclooxygenase-2 Affects Clinical Outcome in Gastric Cancer |
| 12/02/2010 | US20100304375 Influenza Virus Genome Replication and Transcription System in Yeast Cells |
| 12/02/2010 | US20100304374 Methods and tools for discriminating colorectal adenomas and adenocarcinomas |
| 12/02/2010 | US20100304373 Methods for Assessing the Susceptibility of a Human to Diminished Health and Wellness |
| 12/02/2010 | US20100304372 Liver Cancer Methods and Compositions |
| 12/02/2010 | US20100304371 Compositions and methods for detecting mycobacteria |
| 12/02/2010 | US20100304370 Intracellular ph sensor using nucleic acid assemblies |
| 12/02/2010 | US20100304369 Method and apparatus for diagnosing age-related macular degeneration |
| 12/02/2010 | US20100304368 Components and method for enzymatic synthesis of nucleic acids |
| 12/02/2010 | US20100304367 Compositions for real-time, single molecule sequence determination |
| 12/02/2010 | US20100304366 Methods for Determining Virulence and Invasiveness Among Various Staphylococcus Aureus Strains |
| 12/02/2010 | US20100304365 Mutation of prps1 gene causing cmtx5 disease and the use thereof |
| 12/02/2010 | US20100304364 Compositions and methods for monosynaptic transport |
| 12/02/2010 | US20100304363 Peptide compounds for detecting or inhibiting sars coronavirus and application thereof |
| 12/02/2010 | US20100304362 New detection method for cervical hpvs |
| 12/02/2010 | US20100304361 Method and device for monitoring a therapeutic treatment regime |
| 12/02/2010 | US20100304360 Gold nanoparticle hpv genotyping system and assay |
| 12/02/2010 | US20100304359 Multianalyte assay |
| 12/02/2010 | US20100304358 Methods of identifying biological targets and instrumentation to identify biological targets |
| 12/02/2010 | US20100304357 Universal drinking adapter for beverage bottles, and devices and kits for determining small molecules, metal ions, endotoxins, and bacteria, and methods of use thereof |
| 12/02/2010 | US20100304353 Methods of improving a genomic marker index of dairy animals and products |
| 12/02/2010 | US20100303866 Immunogenic peptides and their use in immune disorders |
| 12/02/2010 | US20100303861 Live Attenuated Vaccine Strain for Prevention of Tularemia |
| 12/02/2010 | US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/02/2010 | US20100303832 Genes and polymorphisms associated with amd |
| 12/02/2010 | US20100303829 Hiv vpr-specific t cell receptors |
| 12/02/2010 | US20100303820 Methods of treatment using il-17e antagonists |
| 12/02/2010 | US20100303819 Dcl-1 and uses thereof |
| 12/02/2010 | US20100303813 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness |
| 12/02/2010 | US20100303809 Methods for the detection and quantitation of pten |
| 12/02/2010 | US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes |
| 12/02/2010 | US20100303795 Marker of prostate cancer |
| 12/02/2010 | US20100303785 Novel therapeutics based on tau/microtubule dynamics |
| 12/02/2010 | US20100303773 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activity and use thereof |
| 12/02/2010 | US20100303771 Gaba neuron progenitor cell marker 65b13 |
| 12/02/2010 | US20100303729 Cyanochrome fluorophores |
| 12/02/2010 | US20100303721 Use of Parasitic Biological Agents for Diseases Prevention and Control |
| 12/02/2010 | DE102010021514A1 Use of the determination of protease activity of proteasome for standardization and/or examination of a preparation affecting immune system and as a biomarker for the treatability with a preparation affecting immune system |
| 12/02/2010 | CA2764038A1 Modulation of phospholipase d for the treatment of neurodegenerative disorders |
| 12/02/2010 | CA2763834A1 Biosensors utilizing ink jet-printed biomolecule compatible sol gel inks and uses thereof |
| 12/02/2010 | CA2763618A1 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| 12/02/2010 | CA2763608A1 Methods for detecting gene dysregulations |
| 12/02/2010 | CA2763584A1 Advanced pathogen detection and screening |
| 12/02/2010 | CA2763432A1 Mirna biomarkers for the diagnosis of duchenne muscular dystrophy, its progression and for monitoring therapeutic interventions |
| 12/02/2010 | CA2763321A1 Methods of scoring gene copy number in a biological sample using in situ hybridization |
| 12/02/2010 | CA2763278A1 Novel tissue protective erythropoietin receptor (nepor) and methods of use |
| 12/02/2010 | CA2763199A1 B cell signature associated with tolerance in transplant recipients |
| 12/02/2010 | CA2761817A1 Production of glycoproteins |
| 12/02/2010 | CA2761280A1 Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| 12/01/2010 | EP2256653A2 System and method for integrated analysis of data for characterizing carbohydrate polymers |
| 12/01/2010 | EP2256498A1 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 12/01/2010 | EP2256486A1 Probe reagent for measuring oxidative stress |
| 12/01/2010 | EP2256482A1 System and method for analyzing antibiotic susceptibility of biological samples |
| 12/01/2010 | EP2256478A2 Device and method for detecting molecular interactions |
| 12/01/2010 | EP2256218A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith |
| 12/01/2010 | EP2256217A1 Magnetic particles for nucleic acid sequencing and method of sequencing nucleic acid using the same |
| 12/01/2010 | EP2256216A1 Assay system using a nuclease activity of a nucleic acid polymerase |
| 12/01/2010 | EP2256215A1 Assay system using a nuclease activity of a nucleic acid polymerase |
| 12/01/2010 | EP2256214A1 Methods for the diagnosis and the prognosis of a brain tumor |
| 12/01/2010 | EP2256213A1 Asynchronous primed PCR |
| 12/01/2010 | EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides |
| 12/01/2010 | EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides |
| 12/01/2010 | EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome |
| 12/01/2010 | EP2256196A1 Method for treating a sample that contains biomolecules |
| 12/01/2010 | EP2256193A1 Identification of hypertension susceptibility gene group |
| 12/01/2010 | EP2256190A1 Method of diagnosing risk of myocardial infarction |
| 12/01/2010 | EP2256188A1 Method for increasing enzymatic reactivity |
| 12/01/2010 | EP2256187A1 Hepatocyte lineage cells derived from pluripotent stem cells |
| 12/01/2010 | EP2256186A1 Myocardial grafts and cellular compositions |
| 12/01/2010 | EP2256133A1 Bioconjugation of macromolecules |
| 12/01/2010 | EP2256126A1 New labelling strategies for the sensitive detection of analytes |
| 12/01/2010 | EP2256103A1 Novel indicator platform |
| 12/01/2010 | EP2255880A2 System and method to prevent air bubbles in a hybridization chamber |
| 12/01/2010 | EP2255200A1 BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY |
| 12/01/2010 | EP2255198A2 Detecting neoplasm |
| 12/01/2010 | EP2255190A2 Fish assay for eml4 and alk fusion in lung cancer |
| 12/01/2010 | EP2255184A2 Serotonin transporter gene and treatment of alcoholism |